Insider · CIK 0001639368
Stephen Eric Rowland
Files at DT (Dynatrace, Inc.), KVYO (Klaviyo, Inc.). First filing Oct 17, 2024, latest Dec 17, 2025.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
KVYO: Klaviyo, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 27Weak | Klaviyo, Inc. | $209k 7,104 shares | -2% | +22% from low-41% from high | |
| 27Weak | Klaviyo, Inc. | $195k 7,104 shares | -2% | +14% from low-45% from high | |
| 26Weak | Klaviyo, Inc. | $173k 7,105 shares | -2% | 0% from low-51% from high | |
| 28Weak | Klaviyo, Inc. | $227k 7,105 shares | -2% | +29% from low-36% from high | |
| 27Weak | Klaviyo, Inc. | $224k 7,105 shares | -2% | +31% from low-35% from high | |
| 20Weak | Klaviyo, Inc. | $223k 7,079 shares | -2% | +29% from low-36% from high | |
| 28Weak | Klaviyo, Inc. | $245k 7,079 shares | -2% | +42% from low-30% from high | |
| 33Weak | Klaviyo, Inc. | $494k 14,139 shares | -3% | +43% from low-29% from high | |
| 20Weak | Klaviyo, Inc. | $188k 7,060 shares | -2% | +3% from low-46% from high | |
| 45Moderate | Klaviyo, Inc. | $1.3M 36,710 shares | -13% | - | |
| 27Weak | Klaviyo, Inc. | $182k 4,536 shares | -2% | - | |
| 27Weak | Klaviyo, Inc. | $184k 4,536 shares | -2% | - | |
| 26Weak | Klaviyo, Inc. | $157k 4,536 shares | -2% | - | |
| 20Weak | Klaviyo, Inc. | $674k 18,114 shares | -9% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -3,913 | $29.81 | $117k | 437,485 | Dec 17, 2025 |
| Dec 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -3,191 | $29.01 | $93k | 434,294 | Dec 17, 2025 |
| Nov 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +22,855 | - | - | 454,371 | Nov 18, 2025 |
| Nov 15, 2025 | KVYO Klaviyo, Inc. | FTax withholding Series A Common Stock10b5-1 | -34,326 | $28.61 | $982k | 420,045 | Nov 18, 2025 |
| Nov 17, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +28,457 | - | - | 448,502 | Nov 18, 2025 |
| Nov 17, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -7,104 | $27.39 | $195k | 441,398 | Nov 18, 2025 |
| Nov 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -22,855 | $0.00 | $0 | 387,641 | Nov 18, 2025 |
| Nov 17, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -28,457 | $0.00 | $0 | 359,184 | Nov 18, 2025 |
| Oct 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -7,105 | $24.35 | $173k | 431,516 | Oct 16, 2025 |
| Sep 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -6,905 | $31.90 | $220k | 438,821 | Sep 17, 2025 |
| Sep 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -200 | $31.24 | $6,248 | 438,621 | Sep 17, 2025 |
| Aug 20, 2025 | DT Dynatrace, Inc. | MOption exercise Common Stock | +3,981 | - | - | 20,871 | Aug 21, 2025 |
| Aug 20, 2025 | DT Dynatrace, Inc. | MOption exercise Restricted Stock Unitsderivative | -3,981 | $0.00 | $0 | 0 | Aug 21, 2025 |
| Aug 20, 2025 | DT Dynatrace, Inc. | AGrant or award Restricted Stock Unitsderivative | +4,111 | $0.00 | $0 | 4,111 | Aug 21, 2025 |
| Aug 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +22,855 | - | - | 458,700 | Aug 19, 2025 |
| Aug 15, 2025 | KVYO Klaviyo, Inc. | FTax withholding Series A Common Stock10b5-1 | -34,326 | $31.43 | $1.1M | 424,374 | Aug 19, 2025 |
| Aug 18, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +28,457 | - | - | 452,831 | Aug 19, 2025 |
| Aug 18, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -7,105 | $31.46 | $224k | 445,726 | Aug 19, 2025 |
| Aug 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -22,855 | $0.00 | $0 | 438,953 | Aug 19, 2025 |
| Aug 18, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -28,457 | $0.00 | $0 | 410,496 | Aug 19, 2025 |
| Jul 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -7,079 | $31.56 | $223k | 435,845 | Jul 16, 2025 |
| Jul 15, 2025 | DT Dynatrace, Inc. | MOption exercise Common Stock | +431 | - | - | 16,890 | Jul 16, 2025 |
| Jul 15, 2025 | DT Dynatrace, Inc. | MOption exercise Restricted Stock Unitsderivative | -431 | $0.00 | $0 | 0 | Jul 16, 2025 |
| Jun 16, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -6,779 | $34.59 | $234k | 443,224 | Jun 17, 2025 |
| Jun 16, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -300 | $33.82 | $10k | 442,924 | Jun 17, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -6,560 | $35.06 | $230k | 440,750 | May 16, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -500 | $34.19 | $17k | 440,250 | May 16, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +22,957 | - | - | 463,207 | May 16, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | FTax withholding Series A Common Stock10b5-1 | -34,480 | $34.90 | $1.2M | 428,727 | May 16, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +28,355 | - | - | 457,082 | May 16, 2025 |
| May 16, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -7,079 | $34.86 | $247k | 450,003 | May 16, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -22,957 | $0.00 | $0 | 490,163 | May 16, 2025 |
| May 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -28,355 | $0.00 | $0 | 461,808 | May 16, 2025 |
| Apr 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -7,060 | $26.66 | $188k | 447,310 | Apr 16, 2025 |
| Mar 17, 2025 | KVYO Klaviyo, Inc. | AGrant or award Series A Common Stock | +208,116 | $0.00 | $0 | 454,370 | Mar 18, 2025 |
| Mar 7, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -4,880 | $37.18 | $181k | 278,084 | Mar 7, 2025 |
| Mar 7, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -5,528 | $36.00 | $199k | 272,556 | Mar 7, 2025 |
| Mar 7, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -11,699 | $34.83 | $407k | 260,857 | Mar 7, 2025 |
| Mar 7, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -14,603 | $34.24 | $500k | 246,254 | Mar 7, 2025 |
| Feb 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock | +23,048 | - | - | 283,451 | Feb 19, 2025 |
| Feb 15, 2025 | KVYO Klaviyo, Inc. | FTax withholding Series A Common Stock | -28,751 | $47.00 | $1.4M | 254,700 | Feb 19, 2025 |
| Feb 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock | +28,264 | - | - | 282,964 | Feb 19, 2025 |
| Feb 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative | -23,048 | $0.00 | $0 | 541,384 | Feb 19, 2025 |
| Feb 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative | -28,264 | $0.00 | $0 | 513,120 | Feb 19, 2025 |
| Jan 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +78,154 | - | - | 264,939 | Jan 17, 2025 |
| Jan 15, 2025 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -4,536 | $40.04 | $182k | 260,403 | Jan 17, 2025 |
| Jan 15, 2025 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -78,154 | $0.00 | $0 | 564,432 | Jan 17, 2025 |
| Dec 16, 2024 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +4,536 | - | - | 191,321 | Dec 18, 2024 |
| Dec 16, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -1,436 | $41.42 | $59k | 189,885 | Dec 18, 2024 |
| Dec 16, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -2,800 | $40.13 | $112k | 187,085 | Dec 18, 2024 |
| Dec 16, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -300 | $39.49 | $12k | 186,785 | Dec 18, 2024 |
| Dec 16, 2024 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -4,536 | $0.00 | $0 | 642,586 | Dec 18, 2024 |
| Nov 15, 2024 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +22,957 | - | - | 215,445 | Nov 19, 2024 |
| Nov 15, 2024 | KVYO Klaviyo, Inc. | FTax withholding Series A Common Stock10b5-1 | -28,660 | $35.16 | $1.0M | 186,785 | Nov 19, 2024 |
| Nov 18, 2024 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +4,536 | - | - | 191,321 | Nov 19, 2024 |
| Nov 18, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -4,536 | $34.56 | $157k | 186,785 | Nov 19, 2024 |
| Nov 15, 2024 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -22,957 | $0.00 | $0 | 651,658 | Nov 19, 2024 |
| Nov 18, 2024 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -4,536 | $0.00 | $0 | 647,122 | Nov 19, 2024 |
| Oct 15, 2024 | KVYO Klaviyo, Inc. | CConversion Series A Common Stock10b5-1 | +18,114 | - | - | 210,602 | Oct 17, 2024 |
| Oct 15, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -16,114 | $37.27 | $601k | 194,488 | Oct 17, 2024 |
| Oct 15, 2024 | KVYO Klaviyo, Inc. | SOpen-market sale Series A Common Stock10b5-1 | -2,000 | $36.58 | $73k | 192,488 | Oct 17, 2024 |
| Oct 15, 2024 | KVYO Klaviyo, Inc. | CConversion Series B Common Stockderivative10b5-1 | -18,114 | $0.00 | $0 | 674,615 | Oct 17, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.